None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Males and females aged 30-64 years old 2) Subjects who have received a full explanation of the study, understand its contents, and have given their written consent to participate in the study
Exclusion criteria
Exclusion criteria: 1) Subjects who are undergoing medical treatment or diagnosed as needing medical treatment 2) Subjects who are pregnant, lactation, or planning to become pregnant during this study 3) Subjects who have history of serious disorders (Cerebrovascular disease, Cardiac disorder, Hepatic disorders, Gastrointestinal disorder, Endocrine-related disorder, etc.) 4) Subjects who have or have a history of sleep disorders such as insomnia or sleep apnea syndrome (SAS) 5) Subjects with medication allergies, food allergies, or a serious history of such allergies 6) Subjects who have or have a history of drug addiction or alcoholism 7) Subjects who are judged by the principal investigator to have an irregular lifestyle 8) Subjects who regularly use medicines, supplements, etc. 9) Subjects who urinate more than 3 times during the night 10) Extremely heavy drinkers (more than 60g/day of alcohol) 11) Subjects who have participated in other drug or food trials within the past month, or are willing to participate during this study 12) Subjects who are judged as ineligible to participate in this study by the principal investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of OSA Sleep Inventory MA version after 2 weeks of intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the following items after 2 weeks of intake 1) questionnaires about stress and quality of life 2) salivary markers | — |
Countries
Japan
Contacts
Leverage Brain Inc. Clinical Trial Department